The efficacy of postoperative bridging with dalteparin vs placebo was evaluated in those with AF or mechanical heart valves when warfarin is temporarily interrupted for a surgical procedure.
Investigators report findings from the ACTION trial assessing outcomes of therapeutic vs prophylactic oral anticoagulant use among hospitalized adult patients with COVID-19 and elevated D-dimer concentration.
The longitudinal, prospective study assessed whether an association existed between MI with a silent manifestation and the occurrence of subsequent ischemic stroke.
The first oral blood thinning medication for children was approved by the US Food and Drug Administration, the agency announced Monday.
Researchers conducted a review of patients who were tested for COVID-19 and received aspirin or NSAIDS to assess whether aspirin was protective from death, myocardial infarction, or VTE.
This registry-based cohort study aimed to assess both the frequency of prescription of concomitant aspirin (ASA) and DOAC therapy as well as its effect on clinical outcomes in patients with AF or VTE.
Study authors assessed the effectiveness and safety of DOACs compared with warfarin in patients with valvular atrial fibrillation.
Study authors assessed the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to HF types.
Researchers sought to assess the incidence of thrombotic complications in the second wave of patients with COVID-19, how many patients had diagnostic imaging for these complications, overall mortality, and then compared these outcomes with the first wave.
Researchers analyze platelet and neutrophil activation in COVID-19 patients and its association with venous thromboembolism.
